MedTrace Logo

Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm

NCT02261051 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-04-22

No results posted yet for this study

Summary

Symptom Management, Quality of Life and Satisfaction with Care for Advanced Stage Cancers is the first part of a two part study (The Lancaster Cancer Care Model (LCCM) - Non-Concurrent Control Study). The primary aim of the study is to compare the proportion of advanced cancer patients who have a hospitalization or emergency department visit in the last 6 months of life before and after implementation of a new care model that provides more comprehensive symptom management and supportive care, including earlier referral to palliative care. The secondary comparative aim is to assess measures of quality of life and satisfaction in both groups. This current study is to collect data on the control group only. After system redesign, we will open an intervention arm study to collect data after implementation of the new care model (about 18-24 months from start of control phase).

Conditions

Interventions

OTHER

Standard of care

Patients will be cared for using current standard of care preceding the design and implementation of the LCCM model of care.

Sponsors & Collaborators

  • Lancaster General Hospital

    lead OTHER

Principal Investigators

  • Shanthi Sivendran, MD, MSCR · Lancaster General Ann B. Barshinger Cancer Institute

  • Randy Oyer, MD · Lancaster General Ann B. Barshinger Cancer Institute

  • Nik Buescher · Lancaster General Ann B. Barshinger Cancer Institute

  • Joan Harrold, MD · Palliative Medicine Consultants

  • Barbara Martin, PhD · Lancaster General Research Institute

  • Kristina Newport, MD · Palliative Medicine Consultants

  • Michael Horst, PhD · Lancaster General Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261051 on ClinicalTrials.gov